Bodycote PLC (LON:BOY)‘s stock had its “neutral” rating reaffirmed by research analysts at JPMorgan Chase & Co. in a research report issued on Monday. They currently have a GBX 605 ($7.56) price target on the stock. JPMorgan Chase & Co.’s price target points to a potential upside of 4.22% from the company’s previous close.
BOY has been the topic of several other reports. Canaccord Genuity reiterated a “buy” rating and issued a GBX 680 ($8.50) price objective on shares of Bodycote PLC in a research report on Wednesday, October 12th. Royal Bank Of Canada boosted their target price on shares of Bodycote PLC from GBX 550 ($6.87) to GBX 590 ($7.37) and gave the company a “sector performer” rating in a research note on Monday, August 1st. Credit Suisse Group AG reissued an “outperform” rating on shares of Bodycote PLC in a research note on Monday, October 3rd. Jefferies Group reissued a “buy” rating and issued a GBX 690 ($8.62) target price on shares of Bodycote PLC in a research note on Tuesday, November 1st. Finally, N+1 Singer boosted their target price on shares of Bodycote PLC from GBX 635 ($7.93) to GBX 690 ($8.62) and gave the company a “buy” rating in a research note on Wednesday, October 12th. Four research analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. The company has a consensus rating of “Buy” and an average price target of GBX 660.57 ($8.25).
Bodycote PLC (LON:BOY) remained flat at GBX 580.50 on Monday. 214,346 shares of the company traded hands. The firm’s market cap is GBX 1.10 billion. Bodycote PLC has a one year low of GBX 493.30 and a one year high of GBX 644.50. The firm has a 50-day moving average of GBX 598.51 and a 200-day moving average of GBX 589.64.